Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/5/2019
SIETES contiene 92751 citas

 
 
 1 a 19 de 19 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Bersoff-Matcha SJ, Chamberlain C, Cao C, Kortepeter C, Chong WH. Fournier gangrene associated with sodium–glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases. Ann Intern Med 2019:7 de mayo. [Ref.ID 103108]
3. Cita con resumen
Anónimo. Anti-inflammatoires non stéroïdiens: infections graves, fasciites cervicales. Prescrire 2014;34:832-3. [Ref.ID 98465]
4. Cita con resumen
de Amuriza-Chicharro N, Gastalver-Martin C, Cortijo-Cascajares S, Ferrari-Piquero JM. Fascitis necrosante secundaria al tratamiento con panitumumab. Med Clin (Barc) 2013;141:460-1. [Ref.ID 96512]
5. Cita con resumen
Shamloo BK, Chhabra P, Freedman AN, Potosky A, Malin J, Smith SW. Novel adverse events of bevacizumab in the US FDA Adverse Event Reporting System Database: a disproportionality analysis. Drug Saf 2012;35:507-18. [Ref.ID 93072]
6. Cita con resumen
Anónimo. Panitumumab (Vectibix): risk of necrotising fasciitis. Drug Safety Update 2012;6:septiembre. [Ref.ID 93051]
7.Tiene citas relacionadas Cita con resumen
Gould IM. Community-acquired MRSA: can we control it?. Lancet 2006;368:824-6. [Ref.ID 77860]
8.
Vayalumkal JV, Jadavji T. Children hospitalized with skin and soft tissue infections: a guide to antibacterial selection and treatment. Pediatr Drugs 2006;8:99-111. [Ref.ID 76967]
9.
Nordmann P, Naas T. Transmission of methicillin-resistant Staphylococcus aureus to a microbiologist. N Engl J Med 2005;352:1489-90. [Ref.ID 73346]
10.
Ruiz M E, Yohannes S, Wladyka CG. Pyomyositis caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2005;352:1488-9. [Ref.ID 73345]
11.
Chambers HF. Community-associated MRSA - resistance and virulence converge. N Engl J Med 2005;352:1485-7. [Ref.ID 73344]
12.
Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung T O, Spellberg B. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-53. [Ref.ID 73340]
13.
Beeching NJ, Crowcroft NS. Tetanus in injecting drug users. BMJ 2005;330:208-9. [Ref.ID 72616]
14.
Anónimo. Nimesulide - containing products reevaluated. European Union. WHO Drug Information 2003;17:251. [Ref.ID 68865]
15.
Anónimo. NSAIDs associated with necrotising fasciitis. WHO Pharmaceuticals Newsletter 2000;4:12. [Ref.ID 54579]
16.
Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-12. [Ref.ID 48104]
17. Cita con resumen
Zerr DM et al. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999;103:783-90. [Ref.ID 44450]
18.
Holder EP, Moore PT, Browne BA. Nonsteroidal anti-inflammatory drugs and necrotising fasciitis: an update. Drug Saf 1997;17:369-73. [Ref.ID 36047]
19.
Kahn LH, Styrt BA. Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs. Ann Pharmacother 1997;31:1034-9. [Ref.ID 35089]
Seleccionar todas
 
 1 a 19 de 19